Nik Mehta

Dr. Nikhil Mehta is the Head of Regulatory, Quality and Technical Operations at Anthos Therapeutics.

Dr. Mehta has over 25 years of biopharmaceutical industry experience in Drug Development and Regulatory Affairs. He played a key role in the establishment of two biopharmaceutical companies, Odonate Therapeutics and Sentier Therapeutics and in the approval of several important therapeutic products including Keytruda, Erbitux, Adynovate, Vonvendi, Obizur, Elaprase, Vpriv, and Firazyr. Dr. Mehta previously served as Executive VP and Managing Director at Tang Capital Management, SVP and Global Head of Regulatory Affairs at Baxalta, VP of Regulatory Affairs at Merck & Company, and VP Regulatory Affairs at Shire.

Dr. Mehta holds a Ph.D. in Chemical and Biochemical Engineering from Rutgers University.